LEXICON PHARMACEUTICALS INC | 1,252 Euro | +0,012 +0,97 % | |
| WKN: 936717 ISIN: US5288721047 Ticker-Symbol: LX3 | Frankfurt | 25.05.12 | 17:45 Uhr |
Branche BiotechnologieAktienmarkt NASDAQ Biotech |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 04.05. | Lexicon Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript | 2 | Seeking Alpha | |
| 03.05. | Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results | 8 | PR Newswire | |
| THE WOODLANDS, Texas, May 3, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, today... Mehr lesen zu: Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results | ||||
| 28.03. | Lexicon Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference | 50 | PR Newswire | |
| THE WOODLANDS, Texas, March 27, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that Arthur T. Sands, M.D., Ph.D., Lexicon's president and chief executive officer... Mehr lesen zu: Lexicon Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference | ||||
| 01.03. | Lexicon Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference | 45 | PR Newswire | |
| THE WOODLANDS, Texas, Feb. 29, 2012 /PRNewswire/ --Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Arthur T. Sands, M.D., Ph.D., Lexicon's president and chief executive... Mehr lesen zu: Lexicon Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference | ||||
| 24.02. | Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference | 45 | PR Newswire | |
| THE WOODLANDS, Texas, Feb. 23, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Arthur T. Sands, M.D., Ph.D., Lexicon's president and chief executive officer... Mehr lesen zu: Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference | ||||
| 22.02. | Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2011 Fourth Quarter and Full Year Financial Results | 33 | PR Newswire | |
| THE WOODLANDS, Texas, Feb. 22, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human... Mehr lesen zu: Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2011 Fourth Quarter and Full Year Financial Results | ||||
| 08.02. | Lexicon Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference | 35 | PR Newswire | |
| THE WOODLANDS, Texas, Feb. 7, 2012 /PRNewswire/ --Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Arthur T. Sands, M.D., Ph.D., Lexicon's president and chief executive officer, will... Mehr lesen zu: Lexicon Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference | ||||
| 05.01. | Lexicon Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference | 36 | PR Newswire | |
| THE WOODLANDS, Texas, Jan. 4, 2012 /PRNewswire/ --Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Dr. Arthur T. Sands, president and chief executive officer, will present... Mehr lesen zu: Lexicon Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference | ||||
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
